Follow
Bindu Chamarthi
Bindu Chamarthi
Brigham and Women's Hospital; Harvard University; VeroScience LLC
Verified email at bics.bwh.harvard.edu
Title
Cited by
Cited by
Year
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
SW Dubrey, K Cha, J Anderson, B Chamarthi, J Reisinger, M Skinner, ...
QJM: monthly journal of the Association of Physicians 91 (2), 141-157, 1998
6851998
Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures
P Underwood, R Askari, S Hurwitz, B Chamarthi, R Garg
Diabetes care 37 (3), 611-616, 2014
2162014
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin–angiotensin system in humans
B Chamarthi, GH Williams, V Ricchiuti, N Srikumar, PN Hopkins, ...
American journal of hypertension 24 (10), 1143-1148, 2011
1922011
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis
B Chamarthi, SW Dubrey, K Cha, M Skinner, RH Falk
American Journal of Cardiology 80 (9), 1242-1245, 1997
1561997
Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus
GA Walford, J Davis, AS Warner, RJ Ackerman, LK Billings, B Chamarthi, ...
Metabolism 62 (12), 1772-1778, 2013
832013
A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II
B Chamarthi, JS Williams, GH Williams
Journal of hypertension 28 (5), 1020-1026, 2010
692010
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the …
S Srinivasan, V Kaur, B Chamarthi, KR Littleton, L Chen, AK Manning, ...
Diabetes Care 41 (3), 554-561, 2018
462018
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension
JS Williams, B Chamarthi, MO Goodarzi, LH Pojoga, B Sun, AE Garza, ...
American journal of hypertension 25 (7), 812-817, 2012
452012
Timed bromocriptine-QR therapy reduces progression of cardiovascular disease and dysglycemia in subjects with well-controlled type 2 diabetes mellitus
B Chamarthi, JM Gaziano, L Blonde, A Vinik, RE Scranton, M Ezrokhi, ...
Journal of Diabetes Research 2015, 2015
392015
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses
B Sun, JS Williams, L Pojoga, B Chamarthi, J Lasky-Su, BA Raby, ...
Journal of the Renin-Angiotensin-Aldosterone System 12 (4), 564-571, 2011
362011
Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance
PC Underwood, B Chamarthi, JS Williams, B Sun, A Vaidya, BA Raby, ...
Metabolism 61 (5), 667-671, 2012
352012
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension
B Chamarthi, NS Kolatkar, SC Hunt, JS Williams, EW Seely, NJ Brown, ...
The Journal of Clinical Endocrinology & Metabolism 92 (4), 1340-1346, 2007
352007
Comparison of insulin sensitivity measures in South Asians
S Trikudanathan, A Raji, B Chamarthi, EW Seely, DC Simonson
Metabolism 62 (10), 1448-1454, 2013
312013
Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women
AR Saxena, B Chamarthi, GH Williams, PN Hopkins, EW Seely
Journal of human hypertension 28 (5), 292-297, 2014
282014
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus
PC Underwood, B Chamarthi, JS Williams, A Vaidya, R Garg, GK Adler, ...
The Journal of Clinical Endocrinology & Metabolism 97 (10), 3775-3782, 2012
282012
Early identification of individuals with poorly controlled diabetes undergoing elective surgery: improving A1C testing in the preoperative period
P Underwood, J Seiden, K Carbone, B Chamarthi, A Turchin, AM Bader, ...
Endocrine practice 21 (3), 231-236, 2015
272015
Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty
A Gu, C Wei, HN Robinson, SA Sobrio, J Liu, TP Sculco, PK Sculco
The Journal of Knee Surgery 33 (03), 228-234, 2020
252020
Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin
B Chamarthi, AH Cincotta
Postgraduate Medicine 129 (4), 446-455, 2017
252017
Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin
B Chamarthi, M Ezrokhi, D Rutty, AH Cincotta
Postgraduate Medicine 128 (8), 761-769, 2016
252016
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes
GA Walford, N Colomo, JN Todd, LK Billings, M Fernandez, B Chamarthi, ...
PLoS One 10 (3), e0121553, 2015
252015
The system can't perform the operation now. Try again later.
Articles 1–20